Status:
UNKNOWN
Meta-analysis of 46 FDA Identified Studies on Lipid Markers
Lead Sponsor:
University of Toronto
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
Brief Summary
The FDA have revised the data on soy and concluded that a heart health claim is no longer justified based on more recent studies. They are allowing and established panel for public input. The selected...
Detailed Description
Background: The FDA in their re-evaluation of the scientific evidence for a relationship between soy protein and reduced risk of coronary heart disease (CHD), has revised the data included in the 1999...
Eligibility Criteria
Inclusion
- Studies pre-identified by the FDA \[Docket No. FDA-2017-N-0763\]
Exclusion
- Studies with no viable outcome data
Key Trial Info
Start Date :
March 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2018
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03468127
Start Date
March 7 2018
End Date
May 31 2018
Last Update
March 16 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre
Toronto, Ontario, Canada, M5C 2T2
2
University of Toronto
Toronto, Ontario, Canada, M5S 3E2